Ben Buelow (@benofzongo) profile picture
Joined January 2017
A new kid in the block has arrived in the immunotherapy world of myeloma. TNB-383B! @teneobio @abbvie @PlasmaCellPete @ninashah33 @ravivij @adsouza_md @myelomaMD @benofzongo @WakeCancer @ASH_hematology #mmsm #ASH20
CONGRESS | #ASH20 | Cesar Rodriguez, @myelomatips @wakeforestmed, presented first phase I results of TNB-383B, showing no grade 3 CRS, no split-dosing required, ORR of 80% at doses ≥40 mg, responses up to 39 weeks in heavily pretreated pts with RRMM #myeloma #mmsm
4
14
Beyond first-gen BCMA bispecifics: the Baby Yodas are looking good at #ASH20 #mmsm
2
1
17
Novel Triple Chain BCMA bispecific TNB-383B presented by @myelomatips at #ASH20 with 80% ORR with %80 VGPR or better with durable responses up to 39 weeks. No CRS Grade 3. Looking good #mmsm
3
11
Ben Buelow retweeted
A-oh! Teneo! @teneobio BCMA bispecific showing awesome 80% ORR at highest doses, q 3 week dosing, looks safe and ok to give with low GFR! 🙌 So happy to have this study open at @UCSFCancer Congrats to @myelomatips #mmsm #ASH20
4
11
38